Exagen (XGN) Gross Profit (2018 - 2026)

Exagen has reported Gross Profit for 9 years, with the latest figure at $10.2 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 11.86% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $39.9 million (up 18.56% YoY), and the FY2025 full-year result was $38.8 million, up 17.18% from the prior year.
• Gross Profit for Q1 2026 stood at $10.2 million, up from $9.2 million in the prior quarter.
• The five-year high for Gross Profit was $10.4 million in Q2 2025, with the low at $1.5 million in Q2 2022.
• Historically, Gross Profit has averaged $7.8 million across 5 years, with a median of $8.5 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit slumped 79.13% — and 2023, when it jumped 443.26%.
• Exagen's Gross Profit stood at $6.5 million in 2022, then climbed by 24.77% to $8.1 million in 2023, then gained by 4.08% to $8.5 million in 2024, then gained by 8.6% to $9.2 million in 2025, then grew by 10.85% to $10.2 million in 2026.
• The last three Gross Profit figures came in at $10.2 million (Q1 2026), $9.2 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.